Albert Mwango
Overview
Explore the profile of Albert Mwango including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuzuki S, Ishikawa N, Miyamoto H, Dube C, Kayama N, Watala J, et al.
BMC Pediatr
. 2018 Aug;
18(1):272.
PMID: 30121082
Background: Care of children living with HIV comprises various issues, some considered challenging. One of the challenging areas is the serostatus disclosure to HIV-positive children. This study describes the current...
2.
McCarthy E, Subramaniam H, Prust M, Prescott M, Mpasela F, Mwango A, et al.
PLoS One
. 2017 Apr;
12(4):e0175534.
PMID: 28419106
Introduction: In urban areas, crowded HIV treatment facilities with long patient wait times can deter patients from attending their clinical appointments and picking up their medications, ultimately disrupting patient care...
3.
Luo C, Hirnschall G, Rodrigues J, Romano S, Essajee S, Rogers B, et al.
J Acquir Immune Defic Syndr
. 2017 Apr;
75 Suppl 1:S7-S16.
PMID: 28398992
While the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children (IATT) partnership existed before the Global Plan Towards the Elimination of...
4.
Wang P, Mwango A, Moberley S, Brockman B, Connor A, Kalesha-Masumbu P, et al.
PLoS One
. 2015 Oct;
10(10):e0141455.
PMID: 26513240
Background: We assessed the integration of early infant HIV diagnosis with the expanded programme for immunization in a rural Zambian setting with the aim of determining whether infant and postpartum...
5.
Holmes C, Pillay Y, Mwango A, Perriens J, Ball A, Barreneche O, et al.
AIDS
. 2014 May;
28 Suppl 2:S231-9.
PMID: 24849483
No abstract available.
6.
Ishikawa N, Shimbo T, Miyano S, Sikazwe I, Mwango A, Ghidinelli M, et al.
PLoS One
. 2014 Mar;
9(3):e90991.
PMID: 24604067
Background: Countries are currently progressing towards the elimination of new paediatric HIV infections by 2015. WHO published new consolidated guidelines in June 2013, which now recommend either 'Antiretroviral drugs (ARVs)...
7.
Mulenga L, Musonda P, Mwango A, Vinikoor M, Davies M, Mweemba A, et al.
Clin Infect Dis
. 2014 Mar;
58(10):1473-80.
PMID: 24585558
Background: Although tenofovir disoproxil fumarate (TDF) use has increased as part of first-line antiretroviral therapy (ART) across sub-Saharan Africa, renal outcomes among patients receiving TDF remain poorly understood. We assessed...
8.
Avila D, Althoff K, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, et al.
J Acquir Immune Defic Syndr
. 2014 Jan;
65(1):e8-16.
PMID: 24419071
Objective: To describe the CD4 cell count at the start of combination antiretroviral therapy (cART) in low-income (LIC), lower middle-income (LMIC), upper middle-income (UMIC), and high-income (HIC) countries. Methods: Patients...
9.
Li M, Musonda P, Gartland M, Mulenga P, Mwango A, Stringer J, et al.
J Acquir Immune Defic Syndr
. 2013 Jun;
63(3):e116-9.
PMID: 23760096
No abstract available.
10.
Marseille E, Giganti M, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, et al.
PLoS One
. 2013 Jan;
7(12):e51993.
PMID: 23284843
Background: We estimated the unit costs and cost-effectiveness of a government ART program in 45 sites in Zambia supported by the Centre for Infectious Disease Research Zambia (CIDRZ). Methods: We...